Thomas Charles Reilly

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Stamford, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Tom Reilly
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Charles Reilly

Form 4 holding EVP and CFO

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
94,305
Estimated value
$65,070
Report date
01 Jul 2024
Price
$0.6900
Ownership
Direct
Form 4 holding Chief Financial Officer

Cara Therapeutics, Inc.

Security class
Common Stock
Shares / value
37,811
Estimated value
$46,129
Report date
03 Mar 2022
Price
$1.22
Ownership
Direct
Form 4 holding EVP and CFO

AMARIN CORP PLC\UK

Security class
Stock Option (right to buy)
Shares / value
418,000
Estimated value
Report date
01 Feb 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer

Cara Therapeutics, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
25 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP and CFO

AMARIN CORP PLC\UK

Security class
Restricted Stock Unit
Shares / value
16,666
Estimated value
Report date
01 Jul 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Thomas Charles Reilly

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .